Journal of Diabetes Investigation最新文献_第10页

Glycemic control and renal function decline in patients with chronic coronary syndrome: A multicenter cohort study. 慢性冠状动脉综合征患者的血糖控制和肾功能下降：一项多中心队列研究

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-05-01 Epub Date: 2026-02-27 DOI: 10.1111/jdi.70274

An-Yu Cheng, Chin-Chou Huang, Hsin-Bang Leu, Wei-Hsian Yin, Wei-Kung Tseng, Yen-Wen Wu, Tsung-Hsien Lin, Hung-I Yeh, Kuan-Cheng Chang, Ji-Hung Wang, Chau-Chung Wu, Jaw-Wen Chen

{"title":"Glycemic control and renal function decline in patients with chronic coronary syndrome: A multicenter cohort study.","authors":"An-Yu Cheng, Chin-Chou Huang, Hsin-Bang Leu, Wei-Hsian Yin, Wei-Kung Tseng, Yen-Wen Wu, Tsung-Hsien Lin, Hung-I Yeh, Kuan-Cheng Chang, Ji-Hung Wang, Chau-Chung Wu, Jaw-Wen Chen","doi":"10.1111/jdi.70274","DOIUrl":"10.1111/jdi.70274","url":null,"abstract":"Aims/introduction: Diabetes mellitus significantly contributes to renal complications, especially in patients with coronary artery disease (CAD). Effective glycemic control is important; however, the ideal hemoglobin A1c (HbA1c) targets for this population remain uncertain. This observational cohort study aimed to identify appropriate HbA1c targets for patients with diabetes and chronic coronary syndrome.Materials and methods: This study included 1,223 patients with chronic coronary syndrome, which were identified from a multicenter cohort registry study. Among them, there were 698 patients with diabetes. Patients were categorized based on their diabetes status and HbA1c levels. The primary outcome was the incidence of minor and major renal events, defined as a decline in the estimated glomerular filtration rate (eGFR) of more than 25% and 50%. Cox proportional hazards regression models were employed to assess the impact of glycemic control on renal function.Results: Over a mean follow-up of 3.2 ± 2.0 years, the highest incidences of minor renal events were noted in the group with diabetes and HbA1c ≥ 7.5% (25.1%), followed by diabetes and HbA1c < 6.5% (21.2%). Compared to the group without diabetes, the adjusted hazard ratios (95% confidence intervals) for minor renal events in the groups with diabetes and HbA1c ≥ 7.5%, HbA1c 7.0-7.4%, HbA1c 6.5-6.9%, and HbA1c < 6.5% were 3.06 (2.08-4.50), 1.75 (1.08-2.84), 1.32 (0.81-2.23), and 2.59 (1.58-4.24), respectively.Conclusions: Achieving HbA1c of 6.5 to 6.9% is associated with a reduced risk of renal complications in patients with diabetes and chronic coronary syndrome.","PeriodicalId":190,"journal":{"name":"Journal of Diabetes Investigation","volume":" ","pages":"791-800"},"PeriodicalIF":3.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147300436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Synergistic inhibition of macular vascular permeability in diabetic edema: Ginsenoside Rg3 enhances ranibizumab efficacy by targeting angiopoietin-like protein 4 and vascular endothelial growth factor via neuropilin/RhoA signaling. 协同抑制糖尿病水肿黄斑血管通透性：人参皂苷Rg3通过neuropilin/RhoA信号通路靶向血管生成素样蛋白4和血管内皮生长因子，增强雷尼单抗疗效。

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-05-01 Epub Date: 2026-03-14 DOI: 10.1111/jdi.70285

Jiexin Yu, Xingyu Li, Yanli Liu

{"title":"Synergistic inhibition of macular vascular permeability in diabetic edema: Ginsenoside Rg3 enhances ranibizumab efficacy by targeting angiopoietin-like protein 4 and vascular endothelial growth factor via neuropilin/RhoA signaling.","authors":"Jiexin Yu, Xingyu Li, Yanli Liu","doi":"10.1111/jdi.70285","DOIUrl":"10.1111/jdi.70285","url":null,"abstract":"Aims: This study investigated the molecular mechanisms by which ginsenoside Rg3 combined with ranibizumab alleviates diabetic macular edema (DME), focusing on antagonizing ANGPTL4/VEGF and regulating the NRP/RhoA pathway to reduce vascular permeability.Materials and methods: Transcriptomic sequencing compared blood samples from DME patients and healthy controls, followed by GO/KEGG enrichment analysis. In vitro, human retinal microvascular endothelial cells (HRMECs) were treated with ginsenoside Rg3 (5, 10, 20 μM) alone or combined with ranibizumab (1 mg/mL); cell viability, permeability, and protein expression were assessed. In vivo, diabetic rats received intraperitoneal ginsenoside Rg3 and ranibizumab; ocular pathology, angiogenesis, inflammation, and key protein expression/activity were evaluated.Results: DME patients exhibited significant upregulation of VEGF, ANGPTL4, NRP1 (logFC = 1.9, P < 0.01), and RhoA, associated with angiogenesis/migration/inflammation pathways. In vitro, 10 μM ginsenoside Rg3 optimally reduced HRMEC permeability and suppressed ANGPTL4. Combination therapy further decreased VEGF and ANGPTL4 expression. In vivo, combined treatment significantly reduced retinal edema, angiogenesis, and vascular permeability. It markedly inhibited NRP1 expression and reduced RhoA/ROCK activity.Conclusions: The combination of ginsenoside Rg3 and ranibizumab effectively antagonizes ANGPTL4 and VEGF and regulates the NRP/RhoA pathway, significantly reducing vascular permeability in DME through synergistic action. This provides crucial theoretical support for novel DME combination therapy.","PeriodicalId":190,"journal":{"name":"Journal of Diabetes Investigation","volume":" ","pages":"751-765"},"PeriodicalIF":3.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147454951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Serum CTRP3 and CysC correlate with glucose, lipid, and bone metabolism in elderly patients with type 2 diabetes mellitus complicated with osteoporosis. 老年2型糖尿病合并骨质疏松患者血清CTRP3和CysC与糖、脂、骨代谢相关。

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-05-01 Epub Date: 2026-03-06 DOI: 10.1111/jdi.70263

Yi-Peng Wang, Yong Wang, Tao Chen, Gang Chen, Ze-Yu Yang

{"title":"Serum CTRP3 and CysC correlate with glucose, lipid, and bone metabolism in elderly patients with type 2 diabetes mellitus complicated with osteoporosis.","authors":"Yi-Peng Wang, Yong Wang, Tao Chen, Gang Chen, Ze-Yu Yang","doi":"10.1111/jdi.70263","DOIUrl":"10.1111/jdi.70263","url":null,"abstract":"Objective: This study analyzed the correlation between serum C1q/TNF-related protein 3 (CTRP3) and cystatin C (CysC) and glucose-lipid metabolism, bone mineral density (BMD), and bone metabolism markers in elderly patients with type 2 diabetes mellitus (T2DM) complicated with osteoporosis (OP).Methods: A retrospective analysis was conducted on 235 patients with T2DM admitted to Taizhou Municipal Hospital between January 2021 and June 2024. They were categorized into the T2DM group (n = 131) and the T2DM + OP group (n = 104). A healthy control group (n = 95) was established, comprising elderly individuals without diabetes or OP. Serum CTRP3 and CysC were measured. The correlation between serum CTRP3 and CysC levels and relevant metabolism markers and BMD was analyzed. The diagnostic values of serum CTRP3 and CysC were assessed, as well as their role in T2DM + OP.Results: Serum CTRP3 was lower and CysC was higher in the T2DM + OP group. Serum CTRP3 and CysC levels in the T2DM + OP group were correlated with some indicators of glucose-lipid metabolism and bone metabolism and BMD. The area under the curve (AUC) values of serum CTRP3 and CysC levels in distinguishing T2DM + OP were 0.719 and 0.702 (sensitivity: 60.58%; 61.54%, specificity: 74.05%; 74.05%), respectively, with their combination showing better performance (AUC: 0.773, sensitivity: 76.92%, specificity: 64.89%). Elevated serum CysC (OR: 1.422, 95%CI: 1.161-1.742) and CTRP3 (OR: 0.960, 95%CI: 0.943-0.976) were independent risk and protective factors for T2DM + OP in elderly patients, respectively (all P < 0.05).Conclusion: CTRP3 and CysC combined detection helps distinguish OP in elderly patients with T2DM.","PeriodicalId":190,"journal":{"name":"Journal of Diabetes Investigation","volume":" ","pages":"880-891"},"PeriodicalIF":3.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Evaluation of %CV and average glucose derived from pre- and postprandial 6-point glucose measurements for assessing hypoglycemia risk. 评估餐前和餐后6点血糖测量得出的%CV和平均血糖，以评估低血糖风险。

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-05-01 Epub Date: 2026-03-19 DOI: 10.1111/jdi.70275

Rika Soga, Keiichi Torimoto, Fumi Uemura, Yosuke Okada, Shingo Nakayamada

{"title":"Evaluation of %CV and average glucose derived from pre- and postprandial 6-point glucose measurements for assessing hypoglycemia risk.","authors":"Rika Soga, Keiichi Torimoto, Fumi Uemura, Yosuke Okada, Shingo Nakayamada","doi":"10.1111/jdi.70275","DOIUrl":"10.1111/jdi.70275","url":null,"abstract":"Aims/introduction: This study determined the usefulness of coefficient of variation (%CV) and average glucose (AG) from 6-point pre- and postprandial blood glucose measurements in assessing hypoglycemia risk in type 2 diabetes.Materials and methods: We retrospectively analyzed 24-h continuous glucose monitoring data of 233 patients treated with sulfonylureas or insulin. Hypoglycemia was defined as level 1 (<70 mg/dL) or level 2 (<54 mg/dL).Results: The 6-point AG and %CV were 182.9 mg/dL and 23.9%, respectively, for all patients, whereas they were 155.8 mg/dL and 29.8% in patients with level 1 hypoglycemia. Receiver operating characteristic analysis determined cutoff values of 167.7 mg/dL for AG and 21.6% for %CV for predicting level 1 hypoglycemia. Using these thresholds as hypoglycemia risk factors, the incidence was evaluated in the three groups according to the number of risk factors. The incidence of both levels 1 and 2 hypoglycemia increased significantly with increase in the number of risk factors. Compared to risk factor-free patients, the odds ratios for level 1 hypoglycemia were 12.1 and 1.4 in those with two and one risk factor, respectively.Conclusions: Our findings suggest that the AG and %CV derived from 6-point glucose measurements can be potentially useful for detecting hypoglycemia risk.","PeriodicalId":190,"journal":{"name":"Journal of Diabetes Investigation","volume":" ","pages":"851-858"},"PeriodicalIF":3.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147483837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Risk of end-stage renal disease in Korean patients with type 2 diabetes according to cumulative low-density lipoprotein cholesterol levels. 根据累积低密度脂蛋白胆固醇水平，韩国2型糖尿病患者终末期肾脏疾病的风险

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-05-01 Epub Date: 2026-03-16 DOI: 10.1111/jdi.70282

Da-Yeon Lee, Kyung-Do Han, Ji-Hee Ko, Han-Na Jang, Sun Joon Moon, Hye-Mi Kwon, Se-Eun Park, Won-Young Lee, Eun-Jung Rhee

{"title":"Risk of end-stage renal disease in Korean patients with type 2 diabetes according to cumulative low-density lipoprotein cholesterol levels.","authors":"Da-Yeon Lee, Kyung-Do Han, Ji-Hee Ko, Han-Na Jang, Sun Joon Moon, Hye-Mi Kwon, Se-Eun Park, Won-Young Lee, Eun-Jung Rhee","doi":"10.1111/jdi.70282","DOIUrl":"10.1111/jdi.70282","url":null,"abstract":"Objective: Lifelong cumulative high low-density lipoprotein cholesterol (LDL-C) levels are associated with atherosclerosis burden. This study analyzed the association between cumulative LDL-C levels and the risk of end-stage renal disease (ESRD) in Korean adults with type 2 diabetes (T2D).Research design and methods: The incidence of ESRD was analyzed in Korean type 2 diabetes patients aged >20 years who underwent national health examinations from 2015 to 2016. Cumulative LDL-C levels were categorized based on the number of times the levels were ≥130 mg/dL during the examinations. The risk of ESRD across groups was analyzed using the Kaplan-Meier method and Cox proportional hazards model.Results: Among 318,645 patients, the number of occurrences of cumulative LDL ≥130 mg/dL were 0 (154,535), 1 (63,521), 2 (42,563), 3 (32,423), and ≥4 (25,594). Using a multivariable model with adjustment for multiple confounding variables, the risk of ESRD increased with the number of high cumulative LDL-C: hazard ratio (HR) 1.33 (95% confidence interval [CI] 1.17-1.50), 1.51 (1.29-1.76), 1.99 (1.29-1.76), and 2.05 (1.66-2.54) for 1 to ≥4 occurrences, respectively. In patients taking three oral antidiabetic medications, the HR of ESRD was 1.51 (1.23-1.84), 2.10 (1.66-2.66), 3.07 (2.34-4.03), and 3.11 (2.05-2.72) for 1 to ≥4 occurrences compared with 0, respectively. For patients with diabetes duration ≥10 years, the HR of ESRD was 1.45 (1.24-1.70), 1.93 (1.59-2.35), 2.47 (1.94-3.15), and 2.97 (2.18-4.03) for 1 to ≥4 occurrences, respectively.Conclusions: ESRD risk increased with high cumulative LDL-C levels. This difference was more pronounced in patients with diabetes taking multiple antidiabetic medications and in those with a longer duration of diabetes.","PeriodicalId":190,"journal":{"name":"Journal of Diabetes Investigation","volume":" ","pages":"810-817"},"PeriodicalIF":3.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147466243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dual task performance in adults with type 2 diabetes mellitus: A systematic review with meta-analysis. 成人2型糖尿病患者的双重任务表现：荟萃分析的系统回顾。

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-05-01 Epub Date: 2026-03-02 DOI: 10.1111/jdi.70276

Cristián Barros-Osorio, Eduardo Sandoval-Obando, Cintya Odar-Rojas, Iván Cuyul-Vásquez, David Martínez-Pernía, Walter Sepúlveda-Loyola

{"title":"Dual task performance in adults with type 2 diabetes mellitus: A systematic review with meta-analysis.","authors":"Cristián Barros-Osorio, Eduardo Sandoval-Obando, Cintya Odar-Rojas, Iván Cuyul-Vásquez, David Martínez-Pernía, Walter Sepúlveda-Loyola","doi":"10.1111/jdi.70276","DOIUrl":"10.1111/jdi.70276","url":null,"abstract":"Background: Daily activities require the simultaneous execution of cognitive and motor tasks. Type 2 diabetes mellitus (T2DM) is associated with functional impairments that may compromise dual-task performance, leading to increased dual-task interference.Objective: To compare dual-task performance and dual-task interference between individuals with T2DM and healthy control subjects.Methods: This study followed the reporting recommendations of the PRISMA statement. The literature search was conducted in PubMed, Scopus, WoS, LILACS, and PEDro databases. We included studies involving individuals diagnosed with T2DM aged over 18 years, assessed using any dual-task evaluation protocol and compared to healthy control subjects. Methodological quality was independently assessed using the Joanna Briggs Institute checklist and meta-analyses were performed using JAMOVI software.Results: Of the 1,864 articles initially identified, 6 studies met the inclusion criteria, comprising a total of 468 participants. Individuals with T2DM exhibited poorer motor performance during dual-task evaluations, including reduced gait speed (SMD = -0.74 [95%CI: -1.22 to -0.27], P = 0.002) and longer stride times (SMD = 0.34 [95%CI: 0.03 to 0.65], P = 0.039). Additionally, they demonstrated greater dual-task interference in both motor (SMD = -0.67 [95%CI: -1.16 to -0.19], P = 0.006) and cognitive tasks (SMD = -0.33 [95%CI: -0.66 to -0.03], P = 0.033) compared to healthy control subjects.Conclusion: Individuals with T2DM exhibit poorer dual-task performance and greater dual-task interference. These findings highlight the importance of including DT assessments in the clinical evaluation of individuals with T2DM. However, due to the limited number of studies, further research is warranted.","PeriodicalId":190,"journal":{"name":"Journal of Diabetes Investigation","volume":" ","pages":"859-879"},"PeriodicalIF":3.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147343139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association between continuous glucose monitoring metrics and diabetic retinopathy and albuminuria among Japanese individuals with type 1 diabetes. 日本1型糖尿病患者连续血糖监测指标与糖尿病视网膜病变和蛋白尿之间的关系

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-05-01 Epub Date: 2026-03-17 DOI: 10.1111/jdi.70287

Yuichiro Kondo, Ryo Kubota, Rika Suda, Yukiko Hasegawa, Junko Oya, Satoshi Takagi, Hiroko Takaike, Junnosuke Miura, Tomoko Nakagami

{"title":"Association between continuous glucose monitoring metrics and diabetic retinopathy and albuminuria among Japanese individuals with type 1 diabetes.","authors":"Yuichiro Kondo, Ryo Kubota, Rika Suda, Yukiko Hasegawa, Junko Oya, Satoshi Takagi, Hiroko Takaike, Junnosuke Miura, Tomoko Nakagami","doi":"10.1111/jdi.70287","DOIUrl":"10.1111/jdi.70287","url":null,"abstract":"Aims/introduction: This study aimed to clarify the relationship between glucose metrics measured by continuous glucose monitoring (CGM) and diabetic retinopathy (DR) and albuminuria among Japanese individuals with type 1 diabetes mellitus.Materials and methods: The study included 294 individuals with type 1 diabetes (68.7% women) who underwent intermittent scanned CGM between March and April 2023. Multivariable logistic regression analysis was performed to examine the cross-sectional association of each glucose metric (time in range [TIR], time above range [TAR], time below range, glucose management indicator [GMI], and coefficient of variation [CV]) with DR or albuminuria.Results: The prevalence of DR and albuminuria was 27.6 and 13.6%, respectively. CGM metrics did not differ between individuals with DR and those without. However, individuals with albuminuria had significantly lower TIR and higher TAR than those without. The presence of DR was significantly associated with higher levels of TAR (odds ratio [OR] = 1.04, P < 0.001), GMI (OR = 2.13, P < 0.001), and HbA1c (OR = 2.07, P < 0.001), and with a lower level of TIR (OR = 0.97, P = 0.005). The presence of albuminuria was significantly associated with higher levels of TAR (OR = 1.05, P = 0.002), GMI (OR = 2.28, P = 0.005), and HbA1c (OR = 2.28, P < 0.001), and with a lower level of TIR (OR = 0.95, P = 0.007).Conclusion: Decreased TIR and increased TAR and GMI were independently associated with a higher prevalence of DR and albuminuria in Japanese individuals with type 1 diabetes.","PeriodicalId":190,"journal":{"name":"Journal of Diabetes Investigation","volume":" ","pages":"818-826"},"PeriodicalIF":3.0,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137271/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147472119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Bridging the gap: Strengthening shared care for diabetes in Japan. 弥合差距：加强日本糖尿病的共享护理。

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-04-01 Epub Date: 2026-02-16 DOI: 10.1111/jdi.70266

Yu Kouchi

引用次数: 0

Methodological considerations in interpreting RDW-CV as a biomarker for renal tubular injury in type 2 diabetes. 解释RDW-CV作为2型糖尿病肾小管损伤生物标志物的方法学考虑。

IF 3 3区医学

Journal of Diabetes Investigation Pub Date : 2026-03-01 Epub Date: 2026-01-02 DOI: 10.1111/jdi.70234

Xueting Wang, Lei Chen

引用次数: 0

Methodological concerns regarding fingertip autofluorescence as a biomarker for diabetic vascular complications. 关于指尖自身荧光作为糖尿病血管并发症生物标志物的方法学问题。